New research may help explain recurrent Crohn’s disease in children

FHS
June 28, 2024
6:26 pm

Remarkable new research by a University of Virginia undergraduate may help explain recurrent Crohn’s disease in children and open the door to new ways to treat or even cure the devastating condition.

Bezuclastinib by Cogent Biosciences for Systemic Mastocytosis: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 16, 2024

NIH clarifies restrictions on staff after Trump’s broad freeze sparked chaos

WASHINGTON — The National Institutes of Health’s myriad divisions can start new work on mission-critical research, and continue working on ongoing studies, but cannot publicly

January 27, 2025

Hypochondriasis Linked to Increased Risk of Death

People with hypochondriasis had an increased risk of death from both natural and unnatural causes, according to a Swedish cohort study. In analyses adjusted for

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.